Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Michael O'Riordan

November 14, 2017

News Daily News

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Michael O'Riordan

October 27, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Shelley Wood

September 08, 2017

Presentation ESC 2017

Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation

Presenter: Borja Ibanez

August 28, 2017

Presentation ESC 2017

DETermination of the role of OXygen in suspected Acute Myocardial Infarction

Presenter: Robin Hofmann

August 28, 2017

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

Presentation ESC 2017

Gender Differences in the Decrease of In-Hospital Mortality in Patients with Acute Myocardial Infarction

Presenter: Dragana Radovanovic

August 26, 2017

News Conference News ESC 2017

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Michael O'Riordan

August 26, 2017

News Daily News

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

Yael L. Maxwell

August 14, 2017

News Features

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Ashley Lyles

July 13, 2017

News Daily News

Shingles Strongly Tied to Increase in MI and Stroke Risks

Ashley Lyles

July 06, 2017

News Daily News

Cardiac Testing in Chest Pain Patients Without Ischemia Does Not Reduce Acute MI Admissions

Michael O'Riordan

June 28, 2017

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Todd Neale

May 11, 2017

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

Todd Neale

March 18, 2017

News Daily News

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Michael O'Riordan

March 13, 2017

Advertisement

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

New Performance and Quality Metrics for STEMI and NSTEMI Care

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation

DETermination of the role of OXygen in suspected Acute Myocardial Infarction

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Gender Differences in the Decrease of In-Hospital Mortality in Patients with Acute Myocardial Infarction

Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

Getting High: The Low-down for Cardiologists on Illicit Drugs and Marijuana

Shingles Strongly Tied to Increase in MI and Stroke Risks

Cardiac Testing in Chest Pain Patients Without Ischemia Does Not Reduce Acute MI Admissions

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

Statin-Intolerant Patients Have Significantly Worse Prognosis After MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content